BRUNI, COSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1855
EU - Europa 1315
AS - Asia 143
SA - Sud America 3
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3319
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1849
PL - Polonia 494
IE - Irlanda 268
IT - Italia 263
SE - Svezia 161
CN - Cina 54
JO - Giordania 48
VN - Vietnam 28
DE - Germania 27
GB - Regno Unito 22
FI - Finlandia 14
CH - Svizzera 13
RO - Romania 13
ES - Italia 10
AT - Austria 9
UA - Ucraina 7
CA - Canada 6
NL - Olanda 5
BE - Belgio 4
TR - Turchia 4
BR - Brasile 3
HU - Ungheria 3
SG - Singapore 2
TW - Taiwan 2
AU - Australia 1
EU - Europa 1
HK - Hong Kong 1
IN - India 1
IR - Iran 1
JP - Giappone 1
KR - Corea 1
MK - Macedonia 1
MU - Mauritius 1
RU - Federazione Russa 1
Totale 3319
Salva come PNG Salva come JPEG
Città #
Warsaw 494
Fairfield 342
Dublin 258
Chandler 206
Woodbridge 165
Ashburn 158
Seattle 144
Cambridge 109
Houston 109
Florence 103
Lawrence 89
Wilmington 88
Altamura 83
Princeton 69
Boston 49
Ann Arbor 48
Beijing 45
Dong Ket 26
Buffalo 25
Medford 16
San Diego 16
Falls Church 14
Timisoara 11
Boardman 10
London 10
Norwalk 9
Redwood City 9
Andover 8
Vienna 7
Barcelona 6
Castelliri 6
Lucca 6
Basel 4
Brussels 4
Erzurum 4
Guangzhou 4
Jacksonville 4
Phoenix 4
Toronto 4
Bom Jardim 3
Budapest 3
Düsseldorf 3
Hanover 3
Rome 3
Turin 3
Zurich 3
Bergamo 2
Dearborn 2
La Jolla 2
Milan 2
Romagnano Sesia 2
Saint Paul 2
Sesto Fiorentino 2
Singapore 2
Taipei 2
Trumbull 2
Arnsberg 1
Augusta 1
Bagno A Ripoli 1
Borås 1
Bucharest 1
Capannori 1
Casalnuovo 1
Central 1
Chengdu 1
Chicago 1
Delft 1
Delhi 1
Gunzenhausen 1
Hefei 1
Kingston 1
Kunming 1
Laurel 1
Legnaro 1
Leiden 1
Montevarchi 1
Napoli 1
Redmond 1
Rogliano 1
Rotterdam 1
Savona 1
Seoul 1
Taizhou 1
Tokyo 1
Unterföhring 1
Uzzano 1
Totale 2837
Salva come PNG Salva come JPEG
Nome #
Critical finger ischemia and myocardial fibrosis development after sudden interruption of sildenafil treatment in a systemic sclerosis patient. 223
Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis 217
The "myth" of loss of angiogenesis in systemic sclerosis: A pivotal early pathogenetic process or just a late unavoidable event? 158
Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells 115
18F-fluorodeoxyglucose positron-emission tomography/CT and lung involvement in systemic sclerosis 110
Vascular leaking, a pivotal and early pathogenetic event in systemic sclerosis: should the door be closed? 109
The challenge of pet therapy in systemic sclerosis: evidence for an impact on pain, anxiety, neuroticism and social interaction 97
Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study 92
Decrease of LL-37 in systemic sclerosis: a new marker for interstitial lung disease? 90
Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: the Scleroderma Arrhythmia Clinical Utility Study (SAnCtUS) 88
Calcinosis in systemic sclerosis: subsets, distribution and complications 87
The Renal Resistive Index in systemic sclerosis: Determinants, prognostic implication and proposal for specific age-adjusted cut-offs 86
The safety of iloprost in systemic sclerosis in a real-life experience 84
Preliminary analysis of the Very Early Diagnosis of Systemic Sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis. 77
Effect of Dysmetabolisms and Comorbidities on the Efficacy and Safety of Biological Therapy in Chronic Inflammatory Joint Diseases 77
Evidence for a Derangement of the Microvascular System in Patients with a Very Early Diagnosis of Systemic Sclerosis 72
Enthesopathy and involvement of synovio-entheseal complex in systemic sclerosis: an ultrasound pilot study 71
Pregnancy in systemic sclerosis (SSc): results of systematic review and meta-analysis 70
Very early versus early disease: the evolving definition of the 'many faces' of systemic sclerosis. 64
The renal resistive index, a new biomarker for the follow up of vascular modifications in Systemic Sclerosis 64
Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis 64
Increased plasma levels of the VEGF165b splice variant are associated with the severity of nailfold capillary loss in systemic sclerosis 63
Avascular bone necrosis: An underestimated complication of systemic sclerosis 61
Decreased circulating lymphatic endothelial progenitor cells in digital ulcer-complicated systemic sclerosis 60
Hydroxychloroquine and joint involvement in systemic sclerosis: Preliminary beneficial results from a retrospective case-control series of an EUSTAR center 59
Pleuroparenchymal fibroelastosis in rheumatic autoimmune diseases: a systematic literature review 57
Antioxidant agents help primary Raynaud's phenomenon 52
Early Detection of Cardiac Involvement in Systemic Sclerosis: The Added Value of Magnetic Resonance Imaging 50
Pleuroparenchymal fibroelastosis in patients affected by systemic sclerosis: What should the rheumatologist do? 45
The positive side of the coin: Sars-Cov-2 pandemic has taught us how much Telemedicine is useful as standard of care procedure in real life 42
Combination therapy with Bosentan and Sildenafil improves Raynaud’s phenomenon and fosters the recovery of microvascular involvement in systemic sclerosis 41
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19 39
Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management 37
Quantiferon (QFT) identifies latent tuberculosis (LTB) but does not help the evaluation of the efficacy of prophylaxis in inflammatory arthritides 37
Prognostic value of lung ultrasound B-lines in systemic sclerosis 37
The multifaceted problem of pulmonary arterial hypertension in systemic sclerosis 37
Iloprost use and medical management of systemic sclerosis-related vasculopathy in Italian tertiary referral centers: results from the PROSIT study 36
Bosentan blocks the antiangiogenic effects of sera from systemic sclerosis patients: an in vitro study 35
Computed Tomography Predictors of Mortality or Disease Progression in Systemic Sclerosis–Interstitial Lung Disease: A Systematic Review 35
Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience 32
Very early and early diagnosis of systemic sclerosis 31
Treatment of ulcers in systemic sclerosis 31
Quantitative analysis of pulmonary vasculature in systemic sclerosis at spirometry-gated chest CT 31
The renal resistive index: A new biomarker for the follow-up of vascular modifications in systemic sclerosis 31
Combination of denosumab and biologic DMARDs in inflammatory muscle-skeletal diseases and connective tissue diseases 30
Oral lactobacillus species in systemic sclerosis 29
Ultrashort Echo-Time Magnetic Resonance Imaging Sequence in the Assessment of Systemic Sclerosis-Interstitial Lung Disease 29
Digital Ulcers in Systemic Sclerosis 28
Stressful life events at the onset and during the evolution of systemic sclerosis 27
Recent advances steer the future of systemic sclerosis toward precision medicine 26
Risonanza magnetica polmonare nella sclerosi sistemica: un nuovo approccio promettente per valutare il coinvolgimento polmonare e la progressione. 26
Kidney involvement in systemic sclerosis: From pathogenesis to treatment 23
Lung ultrasound B-lines in systemic sclerosis: cut-off values and methodological indications for interstitial lung disease screening 23
Lung magnetic resonance imaging in systemic sclerosis: a new promising approach to evaluate pulmonary involvement and progression 21
The role of ultrasound in systemic sclerosis: On the cutting edge to foster clinical and research advancement 21
Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS) 18
Serum Organ-Specific Anti-Heart and Anti-Intercalated Disk Autoantibodies as New Autoimmune Markers of Cardiac Involvement in Systemic Sclerosis: Frequency, Clinical and Prognostic Correlates 16
To develop a definition and validated expert recommendations to diagnose primary heart involvement in systemic sclerosis - preliminary pathway to a T2T approach 13
The Use and Utility of Machine Learning in Achieving Precision Medicine in Systemic Sclerosis: A Narrative Review 10
Nursing interventions for patients with rheumatic and musculoskeletal diseases on biological therapies: a systematic literature review. 6
The Role of Bronchoalveolar Lavage in Systemic Sclerosis Interstitial Lung Disease: A Systematic Literature Review 6
Alfabetizzazione sanitaria e pazienti affetti da Sclerosi Sistemica 2
A SYSTEMATIC LITERATURE REVIEW (SLR) ON NURSING SENSITIVE OUTCOMES IN SYSTEMIC SCLEROSIS 2
IL CONTRIBUTO DELLA TELEMEDICINA ALLA GESTIONE DEI PAZIENTI REUMATOLOGICI DURANTE LA PANDEMIA DA SARS-CoV-2 2
GLI INTERVENTI INFERMIERISTICI RIVOLTI AI PAZIENTI AFFETTI DA MALATTIE REUMATICHE SOTTOPOSTI A TERAPIA CON FARMACI BIOLOGICI: REVISIONE SISTEMATICA DELLA LETTERATURA 2
Switching from originator adalimumab to biosimilar SB5 in a rheumatology cohort: persistence on treatment, predictors of drug interruption and safety analysis 2
A systematic review of the literature on nursing sensitive outcomes in scleroderma: towards a structured path led by a nurse case manager 2
Patient preferences for systemic sclerosis treatment: A descriptive study within an Italian cohort 1
ULTRASOUND (US) EVALUATION OF BOWEL VASCULOPATHY IN SYSTEMIC SCLEROSIS (SSC) 1
THE EXPERIENCE OF A RHEUMATOLOGY UNIT DURING THE COVID19 LOCKDOWN: TELEMEDICINE ALLOWS A SAFE FOLLOW UP OF PATIENTS WITH RHEUMATIC DISEASES 1
EFFICACY OF A SELF-TREATMENT PROTOCOL FOR FACE AND TEMPOROMANDIBULAR JOINTS REHABILITATION IN SYSTEMIC SCLEROSIS 1
The Yin-Yang Pharmacomicrobiomics on Treatment Response in Inflammatory Arthritides: A Narrative Review 1
AB1540-HPR NURSING INTERVENTIONS FOR RHEUMATIC MUSCULOSKELETAL DISEASES (RMDS) PATIENTS ON BIOLOGIC THERAPY: A SYSTEMATIC LITERATURE REVIEW (SLR) 1
Systemic sclerosis and primary biliary cholangitis: Longitudinal data to determine the outcomes 1
Nursing interventions for patients with rheumatic and musculoskeletal diseases on biological therapies: a systematic literature review 1
ASSESSMENT OF HEALTH LITERACY IN A COHORT OF SYSTEMIC SCLEROSIS (SSC) PATIENTS 1
Totale 3467
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7284
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7284
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20188 0000 00 00 0008
2018/2019236 5988 106 56 9337265
2019/2020650 33282036 7769 7474 73599512
2020/2021839 385071180 4270 8057 701023247
2021/2022438 12203020 3349 843 172667113
2022/20231121 1032726155 54162 18446 10525504
Totale 3467